# High Flow Nasal Cannula Versus High Velocity Nasal Insufflation in Covid-19

> **NCT05216640** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- COVID-19
- Acute Respiratory Failure

## Interventions

- **DEVICE:** High Flow Oxygen Therapy

## Key facts

- **NCT ID:** NCT05216640
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2023-03
- **Final completion:** 2023-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05216640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05216640, "High Flow Nasal Cannula Versus High Velocity Nasal Insufflation in Covid-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05216640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*